The MED13L Gene Transposition of the Great Arteries Dextro-Looped 1 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the MED13L gene that are associated with heart defects, particularly Transposition of the Great Arteries (d-TGA). d-TGA is a serious congenital condition where the two main arteries leaving the heart are reversed, affecting normal blood flow and oxygen distribution in the body. The test plays a crucial role in early detection, enabling healthcare providers to plan effective treatment strategies and interventions. Priced at 4400 AED, this genetic test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the MED13L gene. Early diagnosis through this test can significantly impact the management and outcome of the condition, offering families vital information for making informed health decisions.
The SCN5A gene ventricular fibrillation paroxysmal familial type 1 genetic test is a specialized diagnostic tool designed to identify mutations in the SCN5A gene, which are associated with a rare form of heart condition known as paroxysmal familial ventricular fibrillation type 1 (PFVF1). This condition is characterized by irregular heartbeats that can lead to sudden cardiac arrest if not properly managed. The test is particularly crucial for individuals with a family history of PFVF1 or unexplained cardiac events, as it can provide vital information for managing the condition and preventing potential life-threatening episodes.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the SCN5A gene. These mutations can affect the function of sodium channels in the heart, leading to the development of ventricular fibrillation, a serious heart rhythm problem.
The cost of the SCN5A gene ventricular fibrillation paroxysmal familial type 1 genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the expertise required to accurately interpret the results, and the potential life-saving information it provides. Individuals undergoing this test can expect a comprehensive analysis of their genetic risk for PFVF1, empowering them with the knowledge to take proactive steps in managing their heart health alongside their healthcare provider.
The GATA4 Gene Ventricular Septal Defect Type 1 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at identifying mutations in the GATA4 gene which are associated with Ventricular Septal Defect Type 1 (VSD1). This condition is a congenital heart defect characterized by a hole in the wall separating the heart's lower chambers, affecting the flow of blood within the heart. The GATA4 gene plays a crucial role in heart development and function, and mutations in this gene can lead to various cardiac anomalies including VSD1.
The test is particularly recommended for individuals with a clinical diagnosis of ventricular septal defect, those with a family history of congenital heart defects, or prospective parents with concerns about genetic inheritance of heart conditions. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the GATA4 gene.
The cost of the GATA4 Gene Ventricular Septal Defect Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive analysis and the use of advanced genetic testing technologies to provide accurate and reliable results. The test offers valuable insights for affected individuals and their families, aiding in the understanding of the genetic basis of the condition, informing clinical management, and guiding decision-making regarding treatment options and family planning.
The CITED2 Gene Ventricular Septal Defect Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the CITED2 gene, which are associated with Ventricular Septal Defect Type 2 (VSD2). VSD2 is a congenital heart defect characterized by one or more openings in the ventricular septum, leading to the mixing of oxygen-rich and oxygen-poor blood, which can result in significant cardiovascular complications if left untreated. The test plays a crucial role in the early detection and management of this condition, offering insights that can guide therapeutic decisions and genetic counseling.
Performed using a sample of the patient's blood or saliva, the test specifically targets the CITED2 gene to identify genetic variations that may increase the risk of developing VSD2. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized technology employed to achieve accurate results. By opting for this genetic test at DNA Labs UAE, patients and healthcare providers can gain valuable information on the genetic predisposition to VSD2, enabling proactive measures and personalized care plans to mitigate the impact of this heart defect on affected individuals and their families.
The RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RYR2 gene. These mutations are known to cause Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Type 1, a rare, potentially life-threatening genetic disorder. CPVT is characterized by an abnormal heart rhythm (arrhythmia) that can lead to fainting spells, seizures, or sudden death, especially during physical activity or emotional stress. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic abnormalities in the RYR2 gene, providing crucial information for the diagnosis, treatment, and management of individuals and families affected by this condition.
Sengers Syndrome is a rare genetic disorder characterized by congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, and lactic acidosis. It is caused by mutations in the AGK gene, which plays a crucial role in mitochondrial function and energy production within cells. The condition follows an autosomal recessive inheritance pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome.
The AGK Gene Sengers Syndrome Genetic Test is a specialized diagnostic tool designed to detect mutations in the AGK gene, confirming the diagnosis of Sengers Syndrome. This test is particularly important for families with a history of the condition or for individuals showing symptoms related to the syndrome. Early diagnosis can aid in the management of symptoms and improve the quality of life for those affected.
Conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, the test provides a comprehensive analysis of the AGK gene for mutations associated with Sengers Syndrome. DNA Labs UAE employs advanced sequencing technologies and methodologies to ensure accurate and reliable results.
The cost of the AGK Gene Sengers Syndrome Genetic Test is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, especially for a condition as complex as Sengers Syndrome. Accurate diagnosis can facilitate targeted interventions, appropriate management strategies, and genetic counseling for affected families, helping them make informed decisions about their health and future.
The KCNH2 Gene Short QT Syndrome Type 1 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the KCNH2 gene, which are associated with Short QT Syndrome Type 1 (SQTS1). SQTS1 is a rare genetic condition characterized by an abnormally short QT interval on an electrocardiogram (ECG), which can lead to life-threatening arrhythmias and sudden cardiac death. The KCNH2 gene plays a crucial role in the electrical activity of the heart, and mutations in this gene can disrupt the heart's normal rhythm.
This genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it for specific mutations in the KCNH2 gene. It is a critical tool for diagnosing SQTS1, allowing for appropriate management and treatment strategies to be implemented, potentially saving lives. The test is particularly recommended for individuals with a family history of Short QT Syndrome or unexplained sudden cardiac deaths.
At DNA Labs UAE, the cost of the KCNH2 Gene Short QT Syndrome Type 1 Genetic Test is 4400 AED. The testing process is conducted with high precision and confidentiality, ensuring patients receive accurate and reliable results. By opting for this test at DNA Labs UAE, individuals can take a proactive step towards understanding their genetic risk for SQTS1 and take necessary preventive measures to protect their heart health.
The KCNQ1 Gene Short QT Syndrome Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the KCNQ1 gene that are associated with Short QT Syndrome Type 2 (SQTS2). This condition is a rare form of heart rhythm disorder characterized by a shortened QT interval on the electrocardiogram (ECG), which can increase the risk of sudden cardiac death due to arrhythmias. The test is crucial for individuals with a family history of SQTS or unexplained cardiac events, as it helps in the early identification and management of the condition. Conducted through a blood sample, the genetic analysis provides comprehensive insights into the KCNQ1 gene, enabling personalized treatment plans and preventive measures for affected individuals and their families. The cost of the test is 4400 AED, reflecting the advanced technology and expertise involved in the genetic analysis at DNA Labs UAE.
The KCNJ2 Gene Short QT Syndrome Type 3 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the KCNJ2 gene, which are associated with Short QT Syndrome Type 3 (SQT3). This condition is a rare, inheritable cardiac anomaly characterized by an abnormally short QT interval on an electrocardiogram (ECG), which can lead to life-threatening arrhythmias and sudden cardiac death. The test plays a critical role in the early detection and management of the syndrome, enabling healthcare providers to implement preventive measures and appropriate treatments to mitigate risks associated with the condition. Priced at 4400 AED, this genetic test is a crucial tool for individuals with a family history of Short QT Syndrome or unexplained cardiac events, offering them an opportunity for informed medical decision-making and personalized healthcare planning.
The SCN5A Gene Sick Sinus Syndrome Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the SCN5A gene, which are associated with Sick Sinus Syndrome Type 1 (SSS1). Sick Sinus Syndrome is a group of heart rhythm disorders (arrhythmias) where the sinus node — the heart's natural pacemaker — doesn't function properly. The SCN5A gene plays a crucial role in the function of heart muscle cells, particularly in the generation and conduction of electrical impulses that regulate heart rhythm. Mutations in this gene can lead to various cardiac issues, including SSS1, characterized by symptoms such as fainting, palpitations, fatigue, or dizziness due to irregular heartbeats.
The test at DNA Labs UAE involves collecting a DNA sample, typically through a blood draw or a cheek swab, to analyze the genetic makeup of the SCN5A gene. This analysis helps in identifying any genetic mutations that may be responsible for the symptoms and conditions related to Sick Sinus Syndrome Type 1. The results from this test can provide valuable information for diagnosis, guiding treatment options, and assessing the risk of passing the condition to future generations.
The cost of the SCN5A Gene Sick Sinus Syndrome Type 1 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the genetic analysis and the specialized expertise required to interpret the results, this cost reflects the comprehensive nature of the test, providing patients and healthcare providers with crucial insights into managing and treating this condition effectively.
